Article
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants.
Nature - 1 Apr 2021
Wang Zijun, Schmidt Fabian, Weisblum Yiska, Muecksch Frauke, Barnes Christopher O, Finkin Shlomo, Schaefer-Babajew Dennis, Cipolla Melissa, Gaebler Christian, Lieberman Jenna A, Oliveira Thiago Y, Yang Zhi, Abernathy Morgan E, Huey-Tubman Kathryn E, Hurley Arlene, Turroja Martina, West Kamille A, Gordon Kristie, Millard Katrina G, Ramos Victor, Da Silva Justin, Xu Jianliang, Colbert Robert A, Patel Roshni, Dizon Juan, Unson-O'Brien Cecille, Shimeliovich Irina, Gazumyan Anna, Caskey Marina, Bjorkman Pamela J, Casellas Rafael, Hatziioannou Theodora, Bieniasz Paul D, Nussenzweig Michel C
Abstract excerpt
Here we report on the antibody and memory B cell responses of a cohort of 20 volunteers who received the Moderna (mRNA-1273) or Pfizer-BioNTech (BNT162b2) vaccine against SARS-CoV-21-4. Eight weeks after the second injection of vaccine, volunteers showed high levels of IgM and IgG anti-SARS-CoV-2 spike protein (S) and receptor-binding-domain (RBD) binding titre. Moreover, the plasma neutralizing activity and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
